Recent years have seen liquid biopsy making significant strides in the healthcare landscape, especially for cancer detection. Known also as multi-cancer detection (MCD) or MCD assays, this test screens for

The Guardant Reveal liquid biopsy test has demonstrated effectiveness in predicting disease recurrence in patients with stage II and higher colorectal cancer (CRC). This was shown through findings from the

Cancer risk is shaped by a complex interplay of genetics, environment, medical history, and lifestyle. Within the realm of cancer genetics, inherited risk factors are a critical area of study.

Cambridge-based life science company, EDX Medical Group plc, has entered into a significant partnership with Caris Life Sciences, a US leader in next-generation AI TechBio and precision medicine. This agreement

EDX Medical has entered into a distribution agreement with Caris Life Sciences, a US company specialising in AI-driven precision medicine. This collaboration will see both companies working together to distribute

EDX Medical Group, a UK-based medical diagnostics company, has entered into a distribution agreement with Caris Life Sciences, a US-based AI and precision medicine firm. This partnership will see the

Andrew Lloyd Webber, renowned for his iconic musicals, has invested in EDX Medical, a pioneering company focused on transforming the diagnosis and treatment of cancer, heart disease, and hospital infections.